MiR-181b is a biomarker of disease progression in Chronic Lymphocytic Leukemia
收藏官方服务：
资源简介：
MiR-181b is a biomarker of disease progression in Chronic Lymphocytic Leukemia
应用场景：
创建时间：
2011-09-22
相关数据集
Characterizing and classifying neuroendocrine neoplasms through microRNA sequencing and data mining
Neuroendocrine neoplasms (NENs) are clinically diverse and incompletely characterized cancers that are challenging to classify. MicroRNAs (miRNAs) are small regulatory RNAs that can be used to classif
DataONE2020-06-16 更新70
Table_3_Establishment of a 4-miRNA Prognostic Model for Risk Stratification of Patients With Pancreatic Adenocarcinoma.xlsx
Pancreatic adenocarcinomas (PAADs) often remain undiagnosed until later stages, limiting treatment options and leading to poor survival. The lack of robust biomarkers complicates PAAD prognosis, and p
NIAID Data Ecosystem20
Table 3_Identification of potential miRNA biomarkers for neurobrucellosis diagnosis.xlsx
BackgroundNeurobrucellosis (NB) is a rare complication of brucellosis that presentis with a variety of clinical symptoms, complicating its diagnosis. This study aimed to analyze the microRNA (miRNA) p
NIAID Data Ecosystem00
Germline Allele-Specific Expression of DAPK1 in Chronic Lymphocytic Leukemia
We previously reported a rare germline variant (c.1-6531) that resulted in allele–specific expression (ASE) of death-associated protein kinase 1 (DAPK1) and predisposition to chronic lymphocytic leuke
Figshare2016-01-18 更新20
Circulating miRNA signature in serum of pateints with primary sclerosing cholangitis (PSC), cholangiocarcinoma (CC) and healthy controls.
RNA was isolated from serum of pateints with PAS, CC and healthy controls. Global microRNA profiling was done using miRNome microRNA Profiler QuantiMir Human PCR Array (#RA660A-1, version 15; BioCat,
NIAID Data Ecosystem20
